Compare Stocks

AgroFresh Solutions, Inc. engages in the provision of food preservation and waste reduction solutions for fresh produce. Its products include SmartFreshTM, HarvistaTM, and FreshCloud. It operates through the following segments: AgroFresh Core and AgroFresh Fruit Protection. The AgroFresh Core produces preservation and waste reduction solutions for growers and packers. The AgroFresh Fruit Protection segment offers fungicides, disinfectants and coatings primarily focused on the citrus market. The company was founded on October 24, 2013 and is headquartered in Philadelphia, PA.

FS Development Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the biotechnology sector. The company was founded in 2020 and is based in San Francisco, California.

Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the research and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as TCR-engineered autologous or allogeneic adoptive cell therapies (ACT) and antibody-like TCR Bispecifics. Its products pipeline includes IMA203 that targets solid tumors, which is in Phase 1b clinical trial; IMA203CD8, a cell therapy product that is in Phase 1b clinical trial; IMA204 that targets tumor stroma, which is in preclinical stage; and IMA30x, an allogenic cellular therapy product candidate, which is in preclinical stage. The company also develops TCR Bispecifics products, including IMA401 and IMA402, which is in Phase 1a clinical trial. The company has a strategic collaboration agreement with MD Anderson Cancer Center to develop multiple T cell and TCR-based adoptive cellular therapies; Celgene Corporation to develop novel adoptive cell therapies targeting multiple cancers; and Genmab A/S to develop T cell engaging bispecific immunotherapies targeting multiple cancer indications. Immatics N.V. is headquartered in Tübingen, Germany.

Pure Acquisition Corp. engages in the provision of merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination. It focuses on energy industry with an emphasis on opportunities in the upstream oil and gas industry in North America. The company was founded on November 13, 2017 and is headquartered in Fort Worth, TX.

Schultze Special Purpose Acquisition Corp. II is a blank check company. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or related business combination with one or more businesses. Schultze Special Purpose Acquisition Corp. II is based in Rye Brook, New York.